Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors

This study has been terminated.

( Withdrawn due to slow accrual )

Study NCT00003926 Information provided by National Cancer Institute (NCI)

First Received: November 1, 1999 Last Updated: August 31, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	March 2008
Estimated Primary Completion Date:	No date given